Longitudinal evolution of risk of coronary heart disease in systemic lupus erythematosus

Journal of Rheumatology

Volumn 39, Issue 5, 2012, Pages 968-973

  Karp, Igor ^a   Abrahamowicz, Michal ^b,c   Fortin, Paul R ^d,e   Pilote, Louise ^b   Neville, Carolyn ^b   Pineau, Christian A ^b   Esdaile, John M ^f,g  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

Coronary heart disease; Longitudinal studies; Risk factors; Systemic lupus erythematosus

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; PREDNISONE;

ADULT; AGE; ARTICLE; BODY MASS; CANADA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE;

ADULT; COHORT STUDIES; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84860769901     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111127     Document Type: Article

References (29)

1. Schattner A, Liang MH. The cardiovascular burden of lupus. A complex challenge. Arch Intern Med 2003;163:1507-9.
2. Lockshin MD, Salmon JE, Roman MJ. Atherosclerosis and lupus: A work in progress [editorial]. Arthritis Rheum 2001;44:2215-7. (Pubitemid 32977486)
3. Abusamieh M, Ash J. Atherosclerosis and systemic lupus erythematosus. Cardiol Rev 2004;12:267-75. (Pubitemid 39121680)
4. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, de Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7. (Pubitemid 32977500)
5. Karp I, Abrahamowicz M, Bartlett G, Pilote L. Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease. Am J Epidemiol 2004;160:707-16. (Pubitemid 39281851)
6. Karp I, Abrahamowicz M, Fortin PR, Pilote L, Neville C, Pineau CA, et al. Recent corticosteroid use and recent disease activity: Independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum 2008;59:169-75. (Pubitemid 351272950)
7. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: The Framingham Offspring Study. Am J Epidemiol 1979;110:281-90. (Pubitemid 10204328)
8. Fortin PR, Abrahamowicz M, Danoff D. Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory test. J Rheumatol 1995;22:2078-83.
9. Kannel W, Wolf P, Garrison R, editors. The Framingham Study: An epidemiological investigation of cardiovascular disease. Washington, DC: US Department of Commerce; 1988.
10. Wilson PW, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 1987;59:91G-94G. (Pubitemid 17085552)
11. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary, NC: SAS Institute Inc.; 1996.
12. Raudenbush SW, Bryk AS. Hierarchical linear models. Applications and data analysis methods. Thousand Oaks, CA: Sage Publications; 2002.
13. Searle SR, Casella G, McCulloch CE. Variance components. New York: Wiley; 1992.
14. Hochberg MC. Update of the 1982 revised criteria for the classification of SLE. Arthritis Rheum 1997;40:1725.
15. Kipen Y, Strauss B J G, Morand EF. Body composition in systemic lupus erythematosus. Br J Rheumatol 1998;37a:514-9.
16. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, Cardona-Munoz EG, Salazar-Paramo M, Gonzalez-Ortiz M, et al. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 2002;22:138-41. (Pubitemid 35002203)
17. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15. (Pubitemid 27084212)
18. Toloza MA, Uribe AG, McGwin G Jr, Alarcon GS, Fessler BJ, Bastian HM, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004;50:3947-57. (Pubitemid 39643943)
19. Roman MJ, Shanker BE, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406. (Pubitemid 37542988)
20. Urowitz MB, Gladman DD, Ibanez D, Fortin PR, Sanchez-Guerrero J, Bae SC, et al. Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort. Arthritis Rheum 2008;59:176-80. (Pubitemid 351272951)
21. Roman MJ, Crow MK, Lockshin MD, Devereux RB, Paget SA, Sammaritano L, et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2007;56:3412-9. (Pubitemid 47585436)
22. Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP, Tektonidou MG, Mastarakou I, Moutsopoulos HM. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: A controlled study. Rheumatology 2003;42:645-51. (Pubitemid 37220873)
23. Ardoin SP, Schanberg LE, Sandborg C, Yow E, Bamhart HX, Mieszkalski KL, et al. Laboratory biomarkers of cardiovascular risk in pediatric SLE: The APPLE baseline cohort. Lupus 2010;19:1315-25.
24. Nikpour MN, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: A longitudinal cohort study. Arthritis Res Ther 2010;12:R125.
25. Bruce IN, Urowitz MB, Gladman DD, Ibanez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study. Arthritis Rheum 2003;48:3159-67. (Pubitemid 37409327)
26. Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003;62:1071-7. (Pubitemid 37323571)
27. Salmon JE, Roman MJ. Accelerated atherosclerosis in systemic lupus erythematosus: Implications for patient management. Curr Opin Rheumatol 2001;13:341-4. (Pubitemid 32929861)
28. Wajed J, Ahmad Y, Durrington PN, Bruce IN. Prevention of cardiovascular disease in systemic lupus erythematosus - proposed guidelines for risk factor management [review]. Rheumatology 2004;43:7-12. (Pubitemid 38088360)
29. Costenbader KH, Liang MH. Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Res Ther 2003;5:178-9. (Pubitemid 36926684)